Press Releases July 23, 2026 08:05 AM

StepStone Group to Announce First Quarter Fiscal 2027 Results on August 6, 2026

StepStone Group scheduled to report Q1 fiscal 2027 earnings on August 6, 2026

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
STEP

StepStone Group Inc., a Nasdaq-listed global private markets investment firm, announced it will release its first quarter fiscal 2027 financial results on August 6, 2026. The company will host a webcast and earnings call to discuss the results and provide insights into its performance and business outlook.

StepStone Group to Announce First Quarter Fiscal 2027 Results on August 6, 2026
STEP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • StepStone manages approximately $885 billion in total capital, including $233 billion in assets under management as of March 31, 2026.
  • The firm focuses on customized private markets investments including private equity, infrastructure, private debt, and real estate.
  • The upcoming earnings release and webcast will provide investors with updated financial performance and strategy execution details.

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that the Company will release its results for the quarter ended June 30, 2026, after the market closes on Thursday, August 6, 2026. This represents results for the first quarter of the fiscal year ending March 31, 2027.

Webcast and Earnings Conference Call

Management will host a webcast and conference call on Thursday, August 6, 2026, at 5:00 pm ET to discuss the Company’s results for the first quarter of the fiscal year ending March 31, 2027. The webcast will be made available on the Shareholders section of the Company's website at https://shareholders.stepstonegroup.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time to register. A replay will also be available on the shareholders website approximately two hours after the conclusion of the event.

To join as a live participant in the question and answer portion of the call, participants must register at https://register-conf.media-server.com/register/BIb7358a7075e744b1b4ef2e638196914a. Upon registering you will receive the dial-in number and a PIN to join the call as well as email confirmation with the details.

About StepStone

StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory and data services to its clients. As of March 31, 2026, StepStone was responsible for approximately $885 billion of total capital, including $233 billion of assets under management. StepStone's clients include some of the world's largest public and private defined benefit and defined contribution pension funds, sovereign wealth funds and insurance companies, as well as prominent endowments, foundations, family offices and private wealth clients, which include high-net-worth and mass affluent individuals. StepStone partners with its clients to develop and build private markets portfolios designed to meet their specific objectives across the private equity, infrastructure, private debt and real estate asset classes.

Contacts

Shareholder Relations:
Seth Weiss
shareholders@stepstonegroup.com
1-212-351-6106

Media:
Jordan Niezelski / Maggie Duffy
Edelman
StepStone@edifi-dje.com


Risks

  • Market volatility could impact StepStone's portfolio performance and asset valuations, affecting reported results.
  • Changes in global economic conditions and private markets investment climate may affect future revenue and asset growth.
  • Regulatory changes or shifts in investor demand for private market assets may create uncertainty in business operations.

More from Press Releases

HP Googlebook 14 Brings Premium Craftsmanship to Google’s Newest Connected Platform Sep 21, 2026 Kratos and GE Aerospace Achieve Significant Program Milestone with Successful Ignition of GEK800 Turbofan Cruise Missile Propulsion System Sep 21, 2026 Microchip Technology Completes Acquisition of Hailo Sep 21, 2026 Palisade Bio to Present at Stifel 2026 Virtual Immunology and Inflammation Forum Sep 21, 2026 NewAmsterdam Pharma and Menarini Group Receive European Commission Approval for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination) Sep 21, 2026